| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
20,989 |
15,730 |
$917K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
23,864 |
17,336 |
$757K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
7,894 |
6,617 |
$40K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,157 |
822 |
$36K |
| 90837 |
Psychotherapy, 53 minutes with patient |
469 |
276 |
$30K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,384 |
1,031 |
$28K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
3,969 |
467 |
$27K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,952 |
1,729 |
$25K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
401 |
318 |
$22K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
360 |
321 |
$22K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
312 |
285 |
$22K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
461 |
366 |
$21K |
| 20610 |
|
746 |
576 |
$19K |
| 80061 |
Lipid panel |
2,993 |
2,389 |
$19K |
| 99307 |
|
3,400 |
2,641 |
$18K |
| 87400 |
|
1,918 |
1,663 |
$18K |
| 99215 |
Prolong outpt/office vis |
253 |
217 |
$17K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
920 |
806 |
$16K |
| 92551 |
|
1,725 |
1,597 |
$13K |
| 90832 |
Psychotherapy, 30 minutes with patient |
296 |
244 |
$13K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,112 |
999 |
$12K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,387 |
1,946 |
$12K |
| 85027 |
|
2,515 |
2,107 |
$11K |
| 71046 |
Radiologic examination, chest; 2 views |
751 |
623 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
156 |
110 |
$9K |
| 82948 |
|
4,500 |
3,656 |
$8K |
| 90834 |
Psychotherapy, 45 minutes with patient |
180 |
126 |
$8K |
| 81003 |
|
4,657 |
3,789 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,614 |
1,920 |
$5K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
153 |
140 |
$5K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
762 |
526 |
$4K |
| 81025 |
|
682 |
575 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
145 |
79 |
$3K |
| 99173 |
|
1,733 |
1,598 |
$3K |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
29 |
26 |
$2K |
| 90791 |
Psychiatric diagnostic evaluation |
12 |
12 |
$975.65 |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
12 |
12 |
$763.80 |
| 93000 |
|
54 |
53 |
$554.48 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
729 |
524 |
$320.74 |
| 86318 |
|
30 |
24 |
$283.36 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,245 |
906 |
$193.08 |
| 74018 |
|
13 |
13 |
$190.50 |
| T1001 |
Nursing assessment / evaluation |
24 |
16 |
$125.71 |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
101 |
16 |
$105.84 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
272 |
197 |
$60.87 |
| 99238 |
Hospital discharge day management, 30 minutes or less |
14 |
13 |
$45.85 |
| 94760 |
|
89 |
80 |
$20.51 |
| 90651 |
|
42 |
39 |
$0.09 |
| 3078F |
|
459 |
412 |
$0.07 |
| 90633 |
|
40 |
36 |
$0.07 |
| 3074F |
|
535 |
471 |
$0.07 |
| 3079F |
|
222 |
203 |
$0.01 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
20 |
18 |
$0.00 |
| 1159F |
|
741 |
638 |
$0.00 |
| 3077F |
|
142 |
134 |
$0.00 |
| 90682 |
|
40 |
30 |
$0.00 |
| 90734 |
|
26 |
26 |
$0.00 |
| 90649 |
|
19 |
16 |
$0.00 |
| 1160F |
|
702 |
601 |
$0.00 |
| 90662 |
|
36 |
34 |
$0.00 |
| 90670 |
|
27 |
24 |
$0.00 |
| 90686 |
|
197 |
177 |
$0.00 |
| 2000F |
|
507 |
441 |
$0.00 |
| 3080F |
|
95 |
87 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
76 |
67 |
$0.00 |
| 3075F |
|
87 |
80 |
$0.00 |
| 1126F |
|
537 |
471 |
$0.00 |
| 1170F |
|
702 |
602 |
$0.00 |
| 3008F |
|
487 |
424 |
$0.00 |
| 1125F |
|
170 |
154 |
$0.00 |